# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000865
Filing Date
2024-05-15
Accepted
2024-05-15 16:03:21
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrkr-20240331x10q.htm iXBRL | 10-Q | 930699
2 | EX-31.1 | mrkr-20240331xex31d1.htm | EX-31.1 | 13536
3 | EX-31.2 | mrkr-20240331xex31d2.htm | EX-31.2 | 13521
4 | EX-32.1 | mrkr-20240331xex32d1.htm | EX-32.1 | 6864
5 | EX-32.2 | mrkr-20240331xex32d2.htm | EX-32.2 | 7041
6 | GRAPHIC | mrkr-20240331x10q001.jpg | GRAPHIC | 12637
7 | GRAPHIC | mrkr-20240331x10q002.jpg | GRAPHIC | 46872
8 | GRAPHIC | mrkr-20240331x10q003.jpg | GRAPHIC | 35002
| Complete submission text file | 0001410578-24-000865.txt |  | 4696063

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | mrkr-20240331.xsd | EX-101.SCH | 38506
10 | EX-101.CAL | mrkr-20240331_cal.xml | EX-101.CAL | 33765
11 | EX-101.DEF | mrkr-20240331_def.xml | EX-101.DEF | 172678
12 | EX-101.LAB | mrkr-20240331_lab.xml | EX-101.LAB | 310882
13 | EX-101.PRE | mrkr-20240331_pre.xml | EX-101.PRE | 265970
69 | EXTRACTED XBRL INSTANCE DOCUMENT | mrkr-20240331x10q_htm.xml | XML | 567144

Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032
Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 24950225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)